Laver v. Eli Lilly & Company | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Laver v. Eli Lilly & Company

Sort by

Viewing results 1‒25 of 1012

Drugs research
Novo Nordisk and Eli Lilly set to face new challenger in weight-loss race
...Other drugmakers could still “win” the race in the rapidly growing obesity market dominated by Novo Nordisk and Eli Lilly, according to the chief executive of biotech company Zealand Pharma....
January 23, 2024
Biotech
Drugmakers race to find alternative suppliers as US cracks down on Chinese biotech
...Eli Lilly and Vertex declined to comment on the talks....
April 11, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Novo Nordisk AS
Novo Nordisk chief seeks more deals to cement weight-loss lead amid ‘hype’
...But the companies do not have a history of protein manufacturing used by Novo Nordisk and its US rival Eli Lilly to make their diabetes and weight-loss products....
March 8, 2024
Novo Nordisk AS
Novo to use Ozempic and Wegovy windfall to invest $7bn a year by 2030
...Eli Lilly chief executive David Ricks described the acquisition as “unusual” on Tuesday and called for competition authorities to look into the deal....
February 12, 2024
Eli Lilly & Co
Eli Lilly weight-loss drug found to address sleep apnoea in trial
...Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage clinical trial, the pharmaceutical group said on Wednesday, adding to evidence that could encourage more...
April 17, 2024
News updates from March 12: US House votes through bill to ban TikTok; Geert Wilders announces he will not be Netherlands PM
Eli Lilly teams with Amazon to dispense Zepbound and other medication
...The addition of Amazon Pharmacy to Eli Lilly’s direct-to-consumer dispensing network is the first time Amazon has partnered with a big drug company since it launched its online pharmacy business in 2020....
March 13, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Eli Lilly & Co
Eli Lilly strikes drug dispensing deal with Amazon
...The addition of Amazon Pharmacy to Eli Lilly’s direct-to-consumer dispensing network is the first time Amazon has partnered with a big drug company since it launched its online pharmacy business in 2020....
March 13, 2024
Eli Lilly & Co
US regulator delays decision on Eli Lilly’s Alzheimer’s drug donanemab
...Patients on the donanemab study had more advanced Alzheimer’s than patients on similar studies, Eli Lilly said....
March 8, 2024
News in-depthEli Lilly & Co
Eli Lilly races to boost capacity as it rolls out rival to Novo Nordisk weight-loss drug
...BSP previously produced Covid antibody treatment bamlanivimab for Eli Lilly....
March 5, 2024
LexHelen Thomas
The Lex Newsletter: Living in an Ozempic world Premium content
...Dear reader, It isn’t often that a company pays good money to criticise customers for buying its product. But that is what Eli Lilly did this week....
March 15, 2024
News updates from February 6: US court denies Trump presidential immunity, Boeing jet in Alaska Airlines blowout was missing bolts
Eli Lilly says diabetes and obesity drugs will boost sales by 20% this year
...Demand for a new class of diabetes and obesity drugs will boost US drugmaker Eli Lilly’s sales by 20 per cent in 2024, pushing its revenues above $40bn, the company said on Tuesday....
February 6, 2024
LexEli Lilly & Co
Eli Lilly’s heavyweight status looks set to last Premium content
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
January 16, 2024
Amazon.com
Amazon hopes anti-obesity drug demand will boost pharmacy business
...The retail giant struck a deal earlier this month to dispense medication on behalf of Zepbound maker Eli Lilly’s direct-to-consumer service LillyDirect....
March 26, 2024
Drugs research
Eli Lilly’s weight-loss drug set for UK launch ‘within weeks’
...Mounjaro will become available “within weeks” in Great Britain for treatment of both diabetes and obesity, after the medicines regulator authorised US pharma company Eli Lilly on Thursday to sell the weight...
January 25, 2024
Eli Lilly & Co
Eli Lilly calls for scrutiny of rival Novo Nordisk’s deal to expand production of weight-loss drug
...Eli Lilly has called for competition regulators to scrutinise an $11bn deal by its main competitor Novo Nordisk to snap up additional manufacturing capacity, as the rivalry between the drugmakers to dominate...
February 6, 2024
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
News in-depthDrugs research
The race to develop the next generation of weight-loss drugs
...Developed respectively by Novo Nordisk and Eli Lilly, they are now being prescribed to millions of people....
April 1, 2024
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...Highlighting continued caution from regulators, the agency last month delayed an approval decision on donanemab, Eli Lilly’s Alzheimer’s drug....
April 22, 2024
Drugs research
Viking Therapeutics shares more than double on ‘statistically significant’ weight-loss trial results
...High demand for weight-loss drugs has helped Novo Nordisk become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s largest pharmaceutical company...
February 27, 2024
News updates from November 8: Iger pledges another $2bn in Disney cost cuts, Draghi delivers downbeat EU forecast
US approves Eli Lilly’s injectable weight loss drug
...The US federal drug regulator has approved Eli Lilly’s injectable diabetes medication for weight loss, as demand for the blockbuster treatments continues to surge....
November 8, 2023
News updates from November 2: Sam Bankman-Fried convicted, BoE leaves rates unchanged
Eli Lilly lowers earnings forecast due to acquisition-related costs
...Eli Lilly lowered its expectations for full-year earnings because of accounting charges related to recent acquisitions, despite beating expectations in the third quarter driven by growth in diabetes and...
November 2, 2023
Pharmaceuticals sector
Approval for Eli Lilly obesity drug sets up rival to Wegovy
...The side effects of Eli Lilly’s and Novo Nordisk’s obesity treatments are very similar, and patients could switch from one to the other, Stanford said....
November 9, 2023
Pharmaceuticals sector
Novo Nordisk and Eli Lilly hoover up smaller obesity drug groups
...Indianapolis-based Eli Lilly, meanwhile, has become the world’s largest pharmaceutical company on the back of sales of its drug Mounjaro for diabetes and strong trial results for its use in weight loss....
October 24, 2023
LexMergers & Acquisitions
Eli Lilly: Point acquisition gives battered biotech sector a boost Premium content
...This is a very small deal for a company as big as Eli Lilly. The drugs giant is riding high on diabetes drug Mounjaro, which has potential use as a weight-loss treatment....
October 3, 2023
Drugs research
Diabetes drug offers hope to Parkinson’s sufferers
...They include the popular new diabetes and weight-loss drugs Ozempic and Wegovy, made by Novo Nordisk, and Mounjaro and Zepbound made by Eli Lilly....
April 3, 2024
Eli Lilly & Co
Eli Lilly to buy cancer specialist Point for $1.4bn
...Eli Lilly, the world’s largest drugmaker, plans to bolster its portfolio of cancer drugs by buying Point Biopharma for $1.4bn, paying a premium of almost 90 per cent to Monday’s closing price....
October 3, 2023

Previous pagePage 1 of 41Next page